Long-QT syndrome: to be or not to be iatrogenesis – a case report

Dragoş Traian Marius Marcu, Alina Hohaci, Mădălina Ioana Chiorescu, Carmen Elena Pleșoianu, Cristian Stătescu, Mircea Balasanian, Liviu Macovei, Cătălina Arsenescu-Georgescu


Long-QT syndrome is a congenital or acquired disorder of the heart’s electrical activity, inducing delayed repolarization that can cause ventricular arrhythmias and sudden cardiac death. Acquired forms can occur as a result of various drugs and given the fact that most patients have multiple comorbidities, the risk of polymedication and iatrogenesis is increasingly high. We present the case of a 60-year-old female admitted to the Cardiology Department for an arrhythmic storm, associating QT interval prolongation. The patient had a known history of atrial fibrillation and was undergoing antiarrhythmic therapy with flecainide. The hypothesis of a drug-induced long-QT syndrome was raised. Multiple ventricular arrhythmias requiring defibrillation occurred and intubation with mechanical ventilation was needed, followed by temporary ventricular pacing. We decided the discontinuation of flecainide therapy but over the next days, the patient presented persistent QT interval prolongation, multiple recurrences of ventricular arrhythmias and recurrent paroxysmal atrial fibrillation. In this context, the initial hypothesis of a flecainide-induced long QT syndrome was invalidated and given the persistent QT interval prolongation (QTc > 480 ms); the hypothesis of a congenital long-QT syndrome was raised. An implantable cardioverter defibrillator implantation was performed. The ECG holter monitoring after implantation showed the disappearance of ventricular arrhythmias, with favorable clinical evolution.


long-QT syndrome, iatrogenesis, arrhythmic storm, ventricular arrhythmias

Full Text:



Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald’s Heart Disease – a textbook of cardiovascular medicine, 10th edition. Philadelphia: Elsevier Saunders, 2015.

Brugada P, Brugada J, Mont L et al. A new approach to the differential diagnosis of a regular tachycardia with wide QRS complex. Circulation 1991; 83:1649.

Wellens HJ, Bar FW, Lie KI. The value of the electroacardiogram in the differential diagnosis of a tachycardia with a widened QRS compex. Am J Med 1978; 64:27-33.

Vereckei A, Duray G, Szenasi G et al. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Hearth Rythm 2008; 5:89-98.

Heist EK, Ruskin NJ. Drug-induced arrhythmia. Circulation 2010; 122:1426-1435.

Tinsdale JE, Miller DA. Drug-Induced Diseases – Prevention, Detection and Management, 2nd edition. Bethesda: American Society of Health-System Pharmacists, 2010.

Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2015; 36:2793-2867.

Konstantopoulou A, Tsikrikas S, Asvestas D, Korantzopoulos P, Letsas KP. Mechanisms of drug-induced proarrhythmia in clinical practice. World J Cardiol 2013; 5(6):175-185.

Woosley RL, Romero KA. QTdrug List [https://crediblemeds.org/ available at 01.31.2017].

DOI: http://dx.doi.org/10.22551/2017.15.0402.10098

Copyright (c) 2017 Dragoş Traian Marius Marcu, Alina Hohaci, Mădălina Ioana Chiorescu, Carmen Elena Pleșoianu, Cristian Stătescu, Mircea Balasanian, Liviu Macovei, Cătălina Arsenescu-Georgescu

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975